Skip to content

ALLERGOS

Active
Private limited companyfounded 2008active for 18 yearsChaussée d'Audenarde(HER) 133a, 7742 Pecq, BelgiumKBO/BCE: BE 0806.486.605
Summary

ALLERGOS has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €111,192 and a net result of €29,652. Equity is growing by about 58% per year across the filed financial years. Its solvency ranks better than 17% of 20,643 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
Size
≈ €200,000turnover 2025, estimated
Equity
€111,192
Profit
€29,652
Turnover estimated from the gross margin
Financial health
92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
  • actionnaire uniqueDirector
2025 accounts filed 35 days late1 of 2 deeds summarised
Why 92raises riskLast filed accounts filed 35 days late; 1 of the last 3 latelowers riskSector: Human health activities (NACE 86)Size: total assets €770,635Figures for financial year 2025 (filed 13-09-2026)Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 36% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Average
Solvency 39+4
equity 14.4% of total assets
Liquidity 61+3
short-term debt 10.3% · cash 9.2%
Profitability 67+2
return on assets 3.8%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,138 companies, NACE 86, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.2%▲ +0.1 percentage points vs 06-2025 08-2025: 0.1%▼ -0.1 percentage points vs 07-2025lowest value 09-2025: 0.1%● unchanged vs 08-2025lowest value 10-2025: 0.1%● unchanged vs 09-2025lowest value 11-2025: 0.1%● unchanged vs 10-2025lowest value 12-2025: 0.1%● unchanged vs 11-2025lowest value 01-2026: 0.1%● unchanged vs 12-2025lowest value 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.3%▲ +0.2 percentage points vs 07-2026 09-2026: 0.4%▲ +0.1 percentage points vs 08-2026highest value 10-2026: 0.1%▼ -0.3 percentage points vs 09-2026
Credit of up to €10,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.01, compared with 1.76 in 2024, above the usual 1.5; short-term debt: 10.3% and cash: 9.2% of total assets), but 85.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 17% on solvency, 39% on liquidity, 12% on profitability and 75% on growth.

The bankruptcy probability was computed on 28-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €770,635
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Last filed accounts filed 35 days late; 1 of the last 3 late
NBB · filings
lowers risk · Figures for financial year 2025 (filed 13-09-2026)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 17% of 20643 sector peers (2025).
NBB · sector comparison
Position among 20643 sector peers
Solvency
better than 17%
← weakest strongest →
neutral · A punctual record breaks
This company filed 3 consecutive financial years on time. The year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 04-09-2026, 35 days late. Weigh it accordingly: of the companies that move to filing 1 to 90 days late, 1.41% are now bankrupt, dissolved or in another special legal status, below the 1.66% of all filers. It is a change in behaviour, not evidence of elevated risk.
NBB · 10 filings
Deviation from the deadline
2025
35 days late
2024
on the day
2023
26 days early
2022
14 days early
2021
25 days late
2020
9 days late
2019
1 day early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 4 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
29-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Equity above €100,000equity €111,192 ▲36.4%
  3. Annual accounts filedfinancial year 2024 · micro…

Financials · financial year 2025, micro format

2025 annual accounts filed late (35 days) Filed on 4 September 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00511662.

Turnover
€260,157
EBIT margin
35.0%
Net result
€29,652▼ 10.8%
2024 · €33,237
Working capital
€80,441▲ 41.8%
2024 · €56,711
Trend over the years

2021 to 2025, 5 financial years 2018 to 2025, 8 financial years

The operating result falls in 2025; 2025 is 11% below 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€0.06m 2025 Net result€0.03m 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line20182019202020212022202320242025
Turnover€0.3m-
Operating result€0.09m-€0.06m▼ 36.3%€0.05m▼ 15.4%€0.07m▲ 47.8%€0.04m▼ 45.4%€0.05m▲ 19.1%€0.07m▲ 50.6%€0.06m▼ 10.8%
Net result€0.05m-€0.02m▼ 52.2%€0.01mbelow the sector's middle half▼ 37.0%€0.01mbelow the sector's middle half▼ 12.9%€0.01mbelow the sector's middle half▲ 8.5%€0.02mbelow the sector's middle half▲ 18.4%€0.03mwithin the sector's middle half▲ 114%€0.03mwithin the sector's middle half▼ 10.8%
EBIT margin35.0%-
Equity-€0.03m--€0.006m▲ 78.0%€0.008mbelow the sector's middle half€0.02mbelow the sector's middle half▲ 158%€0.03mbelow the sector's middle half▲ 66.4%€0.05mwithin the sector's middle half▲ 47.2%€0.08mwithin the sector's middle half▲ 68.8%€0.1mwithin the sector's middle half▲ 36.4%
Total assets€1.1m-€1.1m▼ 3.4%€1.1mabove the sector's middle half▼ 0.8%€0.8mabove the sector's middle half▼ 22.5%€0.8mabove the sector's middle half▼ 2.5%€0.8mabove the sector's middle half▼ 1.7%€0.8mabove the sector's middle half▼ 0.7%€0.8mabove the sector's middle half▼ 1.4%
Debt€1.1m-€1.1m▼ 5.3%€1.1m▼ 2.1%€0.8m▼ 23.8%€0.8m▼ 4.2%€0.7m▼ 3.8%€0.7m▼ 5.2%€0.7m▼ 5.8%
Working capital-€0.006m-€0.006m€0.03mwithin the sector's middle half▲ 370%€0.04mwithin the sector's middle half▲ 23.0%€0.04mwithin the sector's middle half▲ 23.1%€0.04mwithin the sector's middle half▼ 6.2%€0.06mwithin the sector's middle half▲ 38.7%€0.08mwithin the sector's middle half▲ 41.8%
Solvency-2.5%--0.6%▲ 2.0pp0.7%below the sector's middle half▲ 1.3pp2.4%below the sector's middle half▲ 1.7pp4.1%below the sector's middle half▲ 1.7pp6.1%below the sector's middle half▲ 2.0pp10.4%below the sector's middle half▲ 4.3pp14.4%below the sector's middle half▲ 4.0pp
Current ratio0.91-1.09▲ 0.181.39below the sector's middle half▲ 0.291.37below the sector's middle half▼ 0.021.56within the sector's middle half▲ 0.191.60within the sector's middle half▲ 0.031.76within the sector's middle half▲ 0.162.01within the sector's middle half▲ 0.26
Return on assets (ROA)4.2%-2.1%▼ 2.1pp1.3%below the sector's middle half▼ 0.8pp1.5%below the sector's middle half▲ 0.2pp1.6%below the sector's middle half▲ 0.2pp2.0%below the sector's middle half▲ 0.3pp4.3%below the sector's middle half▲ 2.3pp3.8%below the sector's middle half▼ 0.4pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €770,635
Fixed assets €610,923 ▼ 6.0%
Current assets €159,712 ▲ 21.2%
Equity and liabilities €770,635
Equity €111,192 ▲ 36.4%
Debt €659,443 ▼ 5.8%
Debt's share of the balance-sheet total falls from 89.6% to 85.6%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€106,330▼
2024 · €112,340
Cash flow
€72,739▼
2024 · €74,666
Debt to equity
5.93▼
2024 · 8.59
ROE
26.7%▼
2024 · 40.8%
Interest coverage
5.24▲
2024 · 4.92
Debt ≤ 1 year
€79,271▲
2024 · €75,073
Debt > 1 year
€578,888▼
2024 · €625,274
Income taxes
€13,480▼
2024 · €14,854
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 4,107 companies that looked in July 2024 the way this one looks now, 1.0% went bankrupt within 24 months and 98.0% are still going.

  • Small
  • 10 to 20 years old
  • solvency 10 to 30%
  • a profit under 5% of the balance sheet
1.0% went bankrupt
0.9% stopped otherwise
98.0% still going

A further 0.2% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 4,107 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 47 lines
Balance sheet Code20242025
Assets
Total assets20/58€781,887€770,635▼
Fixed assets21/28€650,103€610,923▼
Tangible fixed assets22/27€650,103€610,923▼
Land and buildings22€626,120€588,066▼
Plant, machinery and equipment23€21,996€21,603▼
Furniture and vehicles24€1,987€1,254▼
Current assets29/58€131,784€159,712▲
Amounts receivable within one year40/41€81,555€88,468▲
Trade receivables40€80,555€88,468▲
Other amounts receivable41€1,000€0▼
Cash at bank and in hand54/58€49,407€71,064▲
Deferred charges and accrued income490/1€823€180▼
Equity and liabilities
Total equity and liabilities10/49€781,887€770,635▼
Equity10/15€81,540€111,192▲
Contributions10/11€12,400€12,400=
Reserves13€69,140€98,792▲
Tax-exempt reserves132€22,500€22,500=
Distributable reserves133€46,640€76,292▲
Amounts payable17/49€700,347€659,443▼
Amounts payable after more than one year17€625,274€578,888▼
Financial debts170/4€625,274€578,888▼
Amounts payable within one year42/48€75,073€79,271▲
Current portion of amounts payable after more than one year42€45,293€49,794▲
Financial debts43€3,390€0▼
Credit institutions430/8€3,390€0▼
Trade debts44€472€466▼
Suppliers440/4€472€466▼
Taxes, remuneration and social security45€8,332€11,946▲
Taxes450/3€8,332€11,946▲
Other amounts payable47/48€17,586€17,064▼
Accrued charges and deferred income492/3-€1,284
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€41,428€43,087▲
Other operating charges640/8€2,653€2,834▲
Gross operating margin9900€114,993€109,163▼
Operating profit (loss)9901€70,912€63,243▼
Financial income75/76B€1€184▲
Recurring financial income75€1€184▲
Financial charges65/66B€22,823€20,294▼
Recurring financial charges65€22,823€20,294▼
Profit (loss) for the period before taxes9903€48,091€43,133▼
Income taxes67/77€14,854€13,480▼
Profit (loss) for the period9904€33,237€29,652▼
Profit (loss) for the period to be appropriated9905€33,237€29,652▼
Appropriation of the result
Profit (loss) to be appropriated9906€33,237€29,652▼
Profit (loss) brought forward from the previous period14P€0-
Transfer to equity691/2€33,237€29,652▼
To other reserves6921€33,237€29,652▼

The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20182019202020212022202320242025Change
Turnover70€260,157--------
Non-recurring operating income76A---€38,175€0----
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€47,913€47,413€47,156€31,980€35,123€38,943€41,428€43,087▲ 4.0%
Other operating charges640/8---€3,347€3,057€3,265€2,653€2,834▲ 6.8%
Gross operating margin9900€146,835€112,768€103,743€107,699€77,731€89,301€114,993€109,163▼ 5.1%
Operating profit (loss)9901€90,975€57,926€48,978€72,373€39,551€47,093€70,912€63,243▼ 10.8%
Financial income75/76B---€15€6€1€1€184▲ 125×
Recurring financial income75---€15€6€1€1€184▲ 125×
Financial charges65/66B---€56,088€19,468€22,979€22,823€20,294▼ 11.1%
Recurring financial charges65€44,878€35,828€34,713€56,088€19,468€22,979€22,823€20,294▼ 11.1%
Profit (loss) for the period before taxes9903€46,097€22,098€14,265€16,299€20,089€24,115€48,091€43,133▼ 10.3%
Income taxes67/77€148€123€416€4,233€7,000€8,616€14,854€13,480▼ 9.2%
Profit (loss) for the period9904€45,949€21,976€13,849€12,066€13,089€15,499€33,237€29,652▼ 10.8%
Profit (loss) for the period to be appropriated9905€45,949€21,976€13,849€12,066€13,089€15,499€33,237€29,652▼ 10.8%
Line20182019202020212022202320242025Change
Assets
Total assets20/58€1.1m€1.1m€1.1m€0.8m€0.8m€0.8m€0.8m€0.8m▼ 1.4%
Fixed assets21/28€1.0m€1.0m€1.0m€0.7m€0.7m€0.7m€0.7m€0.6m▼ 6.0%
Tangible fixed assets22/27€1.0m€1.0m€1.0m€0.7m€0.7m€0.7m€0.7m€0.6m▼ 6.0%
Land and buildings22---€0.7m€0.7m€0.7m€0.6m€0.6m▼ 6.1%
Plant, machinery and equipment23----€0.01m€0.02m€0.02m€0.02m▼ 1.8%
Furniture and vehicles24---€0.001m€263€0€0.002m€0.001m▼ 36.9%
Current assets29/58€0.06m€0.07m€0.1m€0.1m€0.1m€0.1m€0.1m€0.2m▲ 21.2%
Amounts receivable within one year40/41€0.06m€0.07m€0.07m€0.08m€0.07m€0.08m€0.08m€0.09m▲ 8.5%
Trade receivables40---€0.07m€0.07m€0.08m€0.08m€0.09m▲ 9.8%
Other amounts receivable41---€0.001m€0.001m€240€0.001m€0▼ 100%
Cash at bank and in hand54/58€0.001m€0.002m€0.04m€0.05m€0.05m€0.03m€0.05m€0.07m▲ 43.8%
Deferred charges and accrued income490/1---€0.003m€0.001m€422€0.001m€180▼ 78.1%
Equity and liabilities
Total equity and liabilities10/49€1.1m€1.1m€1.1m€0.8m€0.8m€0.8m€0.8m€0.8m▼ 1.4%
Equity10/15-€0.03m-€0.006m€0.008m€0.02m€0.03m€0.05m€0.08m€0.1m▲ 36.4%
Contributions10/11€0.01m€0.01m-€0.01m€0.01m€0.01m€0.01m€0.01m=
Reserves13€0.02m€0.02m€0.02m€0.02m€0.02m€0.04m€0.07m€0.1m▲ 42.9%
Tax-exempt reserves132---€0.02m€0.02m€0.02m€0.02m€0.02m=
Distributable reserves133-----€0.01m€0.05m€0.08m▲ 63.6%
Profit (loss) carried forward14-€0.06m-€0.04m-€0.03m-€0.02m-€0.002m€0---
Amounts payable17/49€1.1m€1.1m€1.1m€0.8m€0.8m€0.7m€0.7m€0.7m▼ 5.8%
Amounts payable after more than one year17€1.1m€1.0m€1.0m€0.7m€0.7m€0.7m€0.6m€0.6m▼ 7.4%
Financial debts170/4---€0.7m€0.7m€0.7m€0.6m€0.6m▼ 7.4%
Amounts payable within one year42/48€0.07m€0.07m€0.07m€0.1m€0.08m€0.07m€0.08m€0.08m▲ 5.6%
Current portion of amounts payable after more than one year42---€0.04m€0.04m€0.04m€0.05m€0.05m▲ 9.9%
Financial debts43---€4€0-€0.003m€0▼ 100%
Credit institutions430/8---€4€0-€0.003m€0▼ 100%
Trade debts44€0.004m€0.002m€0.009m€0.01m€0.009m€0.003m€472€466▼ 1.3%
Suppliers440/4---€0.01m€0.009m€0.003m€472€466▼ 1.3%
Taxes, remuneration and social security45---€318€0.007m€0.001m€0.008m€0.01m▲ 43.4%
Taxes450/3---€318€0.007m€0.001m€0.008m€0.01m▲ 43.4%
Other amounts payable47/48---€0.04m€0.02m€0.02m€0.02m€0.02m▼ 3.0%
Accrued charges and deferred income492/3-------€0.001m-
Line20182019202020212022202320242025Change
Profit (loss) for the period9904€45,949€21,976€13,849€12,066€13,089€15,499€33,237€29,652▼ 10.8%
+ Depreciation and write-downs630€47,913€47,413€47,156€31,980€35,123€38,943€41,428€43,087▲ 4.0%
Operating cash flow (approximation)€93,862€69,389€61,005€44,046€48,213€54,442€74,666€72,739▼ 2.6%
Investment in fixed assets (approximation)--€0-€7,873€233,647-€24,615-€37,296-€13,540-€3,907▲ 71.1%
Change in cash-€1,336€36,185€14,252-€3,860-€19,860€20,759€21,658▲ 4.3%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 17 filings with the National Bank
Financial year Type Filed Reference
31-12-2025 micro format 04-09-2026 2026-00511662
31-12-2024 micro format 31-07-2025 2025-00341458
31-12-2023 micro format 05-07-2024 2024-00225526
31-12-2022 micro format 17-07-2023 2023-00253182
31-12-2021 micro format 25-08-2022 2022-20316079
31-12-2020 micro format 09-08-2021 2021-48500234
31-12-2019 micro format 30-07-2020 2020-38500135
31-12-2018 micro format 07-08-2019 2019-44800331
31-12-2017 micro format 30-08-2018 2018-56200533
31-12-2016 micro format 31-08-2017 2017-55800418

Show all 17 filings

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
1 director, last change in 2023
actionnaire unique
Director
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
1 of this company's 2 Belgian Official Gazette deeds has not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.

Mandate history

1 person since 2023, 1 in office
Show
  • Board
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
actionnaire unique
  • Director, since before 19-05-2023
See the board, name and registered office on a given date →

Owners and capital

Capital and shareholders

Capital over the years
  1. 19-05-2023 Converted to unavailable equity

Group and network

Connections & network

1 current director
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

History

ALLERGOS was incorporated on 18 September 2008.1 Total assets fell from €1.1m in 2018 to €770,635 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
04-09
NBB filing Annual accounts filed
financial year 2025 · micro format · 35 days late
2025
31-12
Financial Equity above €100,000equity €111,192 ▲36.4%
A profit in every financial year since 2018 builds equity to €111,192.
31-07
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
05-07
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
17-07
NBB filing Annual accounts filed
financial year 2022 · micro format
19-05
Gazette deed Reappointment: actionnaire unique (director)
Purpose change · Amendment of the articles · Legal-form conversion11 facts ▸
  • General meeting, 03-05-2023
  • Purpose change
  • Amendment of the articles (2 times)
  • Legal-form conversion, “société à responsabilité limitée” (deed in French)
  • Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
  • Other provision, “suppression compte de capitaux propres statutairement indisponible, supprimer et rendre fonds disponibles pour distribution” (deed in French)
  • Other provision, “solvabilité et liquidité, obligation double test avant distribution” (deed in French)
  • General meeting, “prendre résolutions suivantes, assemblée” (deed in French)
  • Capital
  • Power of attorney, Yves Van Roy
  • Director reappointment, actionnaire unique (director)
2022
25-08
NBB filing Annual accounts filed
financial year 2021 · micro format · 25 days late
2021
09-08
NBB filing Annual accounts filed
financial year 2020 · micro format · 9 days late
2020
30-07
NBB filing Annual accounts filed
financial year 2019 · micro format
2019
07-08
NBB filing Annual accounts filed
financial year 2018 · micro format · 7 days late
2018
30-08
NBB filing Annual accounts filed
financial year 2017 · micro format · 30 days late
2017
31-08
NBB filing Annual accounts filed
financial year 2016 · micro format · 31 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 17 annual accounts filed, the latest 10 are here; all 17 are under Financials.
1 of 2 deeds read
About the unread acts

Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded18-09-2008
Financial year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
82300Organisation of conventions and trade shows
85599Other education
E-invoicing
Reachable via Peppol
Peppol ID 0208:0806486605
Also 9925:BE0806486605
Registered 12-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Pecq
exact location from the address register On OpenStreetMap
Ground area
3,938 m²
Building footprint
253 m²
Building volume
1,633 m³
Parcel 57037C0339/00D000, Wallonia · tallest building 9.2 m. Linked by address, not a title deed.
1 parcel
Wallonia 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
57037C0339/00D000 Wallonia 3,938 m² 1 · 253 m² 9.2 m · 2
How the parcels are linked
Good to know
The parcel matches the address exactly.

Articles of association

What the company does

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Name clauseThe name the company operates under according to its articles.
ALLERGOS
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Région wallonne, 2.Siège” (deed in French)

deed of 19-05-2023

Who represents it, and how

Who signsWho may bind the company towards others, for example by signing a contract.
“4. L’administrateur représente la société à l'égard des tiers et en justice, soit en demandant, soit en défendant. En cas de pluralité…”
Board ruleHow the board is made up, meets and takes decisions.
“Durée déterminée, un ou plusieurs” (deed in French)
1 more provision on this in the deed
Power of attorneyA special mandate allowing someone to perform one or more acts on the company's behalf.
One provision in the deed

deed of 19-05-2023

Capital, shares and profit

Kind of sharesWhich classes of shares exist and what rights each class carries.
“Nominatives, registre des actions nominatives avec mentions requises par Code des sociétés et des associations” (deed in French)
Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
“Écrit lettre ordinaire ou e-mail société sous peine nullité, volontaire ou forcée,entre vifs ou pour cause de mort,à titre onéreux ou…” (deed in French)

deed of 19-05-2023

Meetings and financial year

Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
Second Monday of June at 18:00

deed of 19-05-2023

Oversight and winding up

Dissolution ruleWhen and by whom the company can be dissolved.
“Décision de l’assemblée générale délibérant formes prévues pour modifications aux statuts, réunion de tous les titres en une main n’entraîne…” (deed in French)
Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
“Nomination met fin aux pouvoirs de l’organe d’administration, quelque cause et quelque moment que ce soit” (deed in French)

deed of 19-05-2023

Other provisionsOther rules from the articles that fall under none of the themes above.

Other provision: “Sièges administratifs,agences et sièges d'exploitation, établir ou supprimer des sièges administratifs,agences,ateliers,dépôts et…” (deed in French)
Other provision: “Adresse électronique, communication vers cette adresse réputée intervenue valablement” (deed in French)
Other provision: “Actions doivent être libérées à leur émission, appels de fonds” (deed in French)
Other provision: “Indivisibilité des titres” (deed in French)
Other provision: “Un seul administrateur” (deed in French)
Other provision: “Présider conseil et assemblée,superviser relations actionnaires, président conseil” (deed in French)
Other provision: “Restrictions pouvoirs et répartition tâches” (deed in French)
Other provision: “Administrateur non-médecin” (deed in French)
Other provision: “Rémunération des administrateurs, portée aux frais généraux indépendamment des frais de représentation voyages et déplacements” (deed in French)
Other provision: “Contrôle de la société, un ou plusieurs commissaires” (deed in French)
Other provision: “Assemblées générales extraordinaires, 21” (deed in French)
Other provision: “Convocations aux assemblées générales, courrier électronique” (deed in French)
Other provision: “Toutes décisions relevant de l'assemblée générale, assemblée générale par procédure écrite” (deed in French)
Other provision: “Admission à l'assemblée générale, droits non suspendus; si seul droit de vote suspendu peut participer sans voter” (deed in French)
Other provision: “Délibérations,droits de vote,procuration et décès d’un actionnaire, chaque action donne droit à une voix,sous réserve dispositions légales…” (deed in French)
Other provision: “Organe d’administration, 3 semaines” (deed in French)
Other provision: “Pouvoirs de l’assemblée générale, exercés par l’assemblée générale des actionnaires,ceux conférés par le Code des sociétés et des…” (deed in French)
Other provision: “Répartition–réserves, honoraires générés par activité médicale facturés et perçus au nom et pour compte de la société,repris au compte de…” (deed in French)
Liquidation distribution: “Apurement dettes,charges et frais ou consignation montants nécessaires, actif net réparti entre actionnaires en proportion des actions,biens…” (deed in French)
Other provision: “Exécution des statuts,sommations,assignations,significations et toute communication, Élection de domicile” (deed in French)
Other provision: “Tribunaux du siège, litiges entre société,actionnaires,administrateurs,commissaires et liquidateurs relatifs aux affaires de la société et…” (deed in French)
Other provision: “Clauses contraires aux dispositions impératives censées non écrites, Droit commun” (deed in French)
8 more provisions in the deed, see the deed of 19-05-2023

deed of 19-05-2023